Перейти к информации о продукте
1 из 1

Zürich BioGenix

BPC-157 · 5mg

BPC-157 · 5mg

Обычная цена €69,00 EUR
Обычная цена Цена со скидкой €69,00 EUR
Распродажа Продано
Налоги включены.
Количество

BPC-157 (Body Protection Compound-157) — Lyophilized Powder

Compound: (Pentadecapeptide)
Strength: 5 mg per vial
Chemical Formula: C₆₂H₉₈N₁₆O₂₂
Molecular Weight: 1419.53 g/mol
Purity: >99% (HPLC verified)
Form: Lyophilized (freeze-dried) powder
Storage (unopened): Refrigerate at 2°C – 8°C (36°F – 46°F)

Quality Control (Certificate of Analysis)
Appearance: White to off-white powder — Conforms
Identification (LC-MS/MS): Confirmed
Purity (HPLC-UV): >99%
Form: Lyophilized powder — Conforms

Manufactured by: Zürich Biogenix AG, Zurich, Switzerland. Batch-specific Certificate of Analysis provided with each shipment.

For Research Use Only. Not for human or veterinary use. Not a drug, food additive, or cosmetic. Not intended for diagnosis, treatment, cure, or prevention of any disease.

Просмотреть всю информацию
🇨🇭
Swiss Made Zurich since 1998
🔬
HPLC Verified >99% Purity Guaranteed
📋
COA Every Batch Lot-Traceable Compounds
❄️
Cold Chain Maintained End-to-End
🏛️
EU Compliant REACH / Research Use

Research summary

Most published studies on BPC-157 are preclinical. Rodent models have been used to investigate tendon, ligament, muscle and gastrointestinal tissue responses, and cell studies have looked at fibroblast migration and blood vessel formation. Human clinical evidence is sparse, and BPC-157 is not an approved medicine. This summary describes what the literature has investigated. It is not a claim about the effects of our product, which is supplied for laboratory research only.

Mechanism of action

BPC-157 is a synthetic pentadecapeptide (15 amino acids) whose sequence is derived from a protein fragment first isolated from human gastric juice. In published preclinical work, mostly in rodent and cell models, researchers have examined its interaction with angiogenic signalling (including VEGF receptor 2 expression), the nitric oxide system, and cytoskeletal and migration pathways in fibroblasts. The exact molecular target has not been fully defined, and human data are very limited.

Chemical properties

Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 residues). Molecular formula: C62H98N16O22. Molecular weight: approx. 1419.5 g/mol. Form: lyophilised powder. Purity and identity: see the batch Certificate of Analysis (HPLC and mass spectrometry).

Storage and handling

Supplied as a lyophilised (freeze-dried) powder. Store sealed, cold, dry and protected from light, as stated on the Certificate of Analysis and product label. Allow the vial to reach room temperature before opening to limit condensation. Avoid repeated temperature cycling and humidity exposure. For laboratory research use only.

Literature references

Selected PubMed records on BPC-157, scientific background only, not claims about our product. PMID 40005999: BPC-157 literature and patent review. PMID 40756949: systematic review of BPC-157 in orthopaedic sports medicine. PMID 34267654: review of BPC-157 and wound healing. Open any record at https://pubmed.ncbi.nlm.nih.gov/PMID/ . More: https://pubmed.ncbi.nlm.nih.gov/?term=BPC-157

For laboratory research use only. Not for human or veterinary use. Nothing on this page is medical advice.